Rona Jeffrey A
SEC CIK 1311404 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | CBFO | 156.3K | — | $14.6K | 5 | 2024-02-22 | 2026-02-26 |
Most active insiders at OVID, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALEXANDER MARGARET A. | Pres, CEO, Dir | — | $16.9K |
| 2 | Rona Jeffrey A | CBFO | — | $12.4K |
| 3 | Fitzgerald Kevin Joseph | Dir | — | — |
| 4 | Carter Charles Ross | CFO | — | — |
| 5 | Takeda Pharmaceuticals U.S.A., Inc. | 10% | — | — |
| 6 | Friedman Bart | Dir | — | — |
| 7 | LEVIN JEREMY M | Executive COB, Dir | — | — |
| 8 | PAPADOPOULOS STELIOS | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-02-26 | OVID | Ovid Therapeutics Inc. | Rona Jeffrey A | CBFO | A - Grant | $0.00 | +68.1K | 156.3K | +77% | $0 |
| D | 2026-03-02 | 2026-02-23 | OVID | Ovid Therapeutics Inc. | Rona Jeffrey A | CBFO | S - Sale | $1.45 | -8,541 | 88.2K | -9% | -$12.4K |
| 2025-02-28 | 2025-02-26 | OVID | Ovid Therapeutics Inc. | Rona Jeffrey A | CBFO | S - Sale | $0.56 | -3,902 | 68.0K | -5% | -$2,185 | |
| D | 2025-02-24 | 2025-02-20 | OVID | Ovid Therapeutics Inc. | Rona Jeffrey A | CBFO | A - Grant | $0.00 | +43.8K | 71.9K | +156% | $0 |
| D | 2024-02-26 | 2024-02-22 | OVID | Ovid Therapeutics Inc. | Rona Jeffrey A | CBFO | A - Grant | $0.00 | +28.1K | 28.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations